Macular Degeneration Treatment Market Report

China Macular Degeneration Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Aug 15, 2023
  • PAGES：179
  • REPORT CODE：GMM1737767
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Macular Degeneration Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • REGENXBIO Inc

    • Panoptica

    • Oxurion

    • Ocugen Inc

    • Bayer AG

    • Clover Therapeutics

    • Bausch Health Companies Inc

    • Aerie Pharmaceutical Inc

    • Pfizer Inc

    • Novartis AG

    • MeiraGTx

    • ONL Therapeutics

    By Type:

    • Dry Age-related Macular Degeneration

    • Wet Age-related Macular Degeneration

    By Application:

    • Other Sales Channels

    • Hospitals

    • Ambulatory Surgical Centers

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Macular Degeneration Treatment Market Overview 2018-2029

    • 1.1 China Macular Degeneration Treatment Industry Development Overview

    • 1.2 China Macular Degeneration Treatment Industry Development History

    • 1.3 China Macular Degeneration Treatment Industry Market Size (2018-2029)

    • 1.4 China Macular Degeneration Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Macular Degeneration Treatment Production Volume, Production Value and Growth Rate of Dry Age-related Macular Degeneration (2018-2029)

      • 1.4.2 China Macular Degeneration Treatment Production Volume, Production Value and Growth Rate of Wet Age-related Macular Degeneration (2018-2029)

    • 1.5 China Macular Degeneration Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Macular Degeneration Treatment Sales Volume, Sales Value and Growth Rate of Other Sales Channels (2018-2029)

      • 1.5.2 China Macular Degeneration Treatment Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.3 China Macular Degeneration Treatment Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

    • 1.6 China Macular Degeneration Treatment Market Analysis by Region

      • 1.6.1 North China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Macular Degeneration Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Macular Degeneration Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Macular Degeneration Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Macular Degeneration Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Macular Degeneration Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Macular Degeneration Treatment Industry Development

    Chapter 3 Macular Degeneration TreatmentIndustry Chain Analysis

    • 3.1 Macular Degeneration Treatment Industry Chain

    • 3.2 Macular Degeneration Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Macular Degeneration Treatment Market

    • 3.3 Macular Degeneration Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Macular Degeneration Treatment Market

    Chapter 4 China Macular Degeneration Treatment Market, by Type

    • 4.1 China Macular Degeneration Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Macular Degeneration Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Macular Degeneration Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Macular Degeneration Treatment Production Volume and Growth Rate of Dry Age-related Macular Degeneration

      • 4.5.2 China Macular Degeneration Treatment Production Volume and Growth Rate of Wet Age-related Macular Degeneration

    Chapter 5 China Macular Degeneration Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Macular Degeneration Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Macular Degeneration Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Macular Degeneration Treatment Market Size and Growth Rate of Other Sales Channels

      • 5.5.2 China Macular Degeneration Treatment Market Size and Growth Rate of Hospitals

      • 5.5.3 China Macular Degeneration Treatment Market Size and Growth Rate of Ambulatory Surgical Centers

    Chapter 6 China Macular Degeneration Treatment Market, by Region

    • 6.1 China Macular Degeneration Treatment Production Volume and Production Value, by Region

    • 6.2 China Macular Degeneration Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Macular Degeneration Treatment Market Analysis

    • 7.1 North China Macular Degeneration Treatment Market, by Type

    • 7.2 North China Macular Degeneration Treatment Market, by Application

    Chapter 8 Central China Macular Degeneration Treatment Market Analysis

    • 8.1 Central China Macular Degeneration Treatment Market, by Type

    • 8.2 Central China Macular Degeneration Treatment Market, by Application

    Chapter 9 South China Macular Degeneration Treatment Market Analysis

    • 9.1 South China Macular Degeneration Treatment Market, by Type

    • 9.2 South China Macular Degeneration Treatment Market, by Application

    Chapter 10 East China Macular Degeneration Treatment Market Analysis

    • 10.1 East China Macular Degeneration Treatment Market, by Type

    • 10.2 East China Macular Degeneration Treatment Market, by Application

    Chapter 11 Northeast China Macular Degeneration Treatment Market Analysis

    • 11.1 Northeast China Macular Degeneration Treatment Market, by Type

    • 11.2 Northeast China Macular Degeneration Treatment Market, by Application

    Chapter 12 Southwest China Macular Degeneration Treatment Market Analysis

    • 12.1 Southwest China Macular Degeneration Treatment Market, by Type

    • 12.2 Southwest China Macular Degeneration Treatment Market, by Application

    Chapter 13 Northwest China Macular Degeneration Treatment Market Analysis

    • 13.1 Northwest China Macular Degeneration Treatment Market, by Type

    • 13.2 Northwest China Macular Degeneration Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 REGENXBIO Inc

        • 14.1.1 REGENXBIO Inc Company Profile

        • 14.1.2 REGENXBIO Inc Macular Degeneration Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Panoptica

        • 14.2.1 Panoptica Company Profile

        • 14.2.2 Panoptica Macular Degeneration Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Oxurion

        • 14.3.1 Oxurion Company Profile

        • 14.3.2 Oxurion Macular Degeneration Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Ocugen Inc

        • 14.4.1 Ocugen Inc Company Profile

        • 14.4.2 Ocugen Inc Macular Degeneration Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Bayer AG

        • 14.5.1 Bayer AG Company Profile

        • 14.5.2 Bayer AG Macular Degeneration Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Clover Therapeutics

        • 14.6.1 Clover Therapeutics Company Profile

        • 14.6.2 Clover Therapeutics Macular Degeneration Treatment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Bausch Health Companies Inc

        • 14.7.1 Bausch Health Companies Inc Company Profile

        • 14.7.2 Bausch Health Companies Inc Macular Degeneration Treatment Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Aerie Pharmaceutical Inc

        • 14.8.1 Aerie Pharmaceutical Inc Company Profile

        • 14.8.2 Aerie Pharmaceutical Inc Macular Degeneration Treatment Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Pfizer Inc

        • 14.9.1 Pfizer Inc Company Profile

        • 14.9.2 Pfizer Inc Macular Degeneration Treatment Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Novartis AG

        • 14.10.1 Novartis AG Company Profile

        • 14.10.2 Novartis AG Macular Degeneration Treatment Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 MeiraGTx

        • 14.11.1 MeiraGTx Company Profile

        • 14.11.2 MeiraGTx Macular Degeneration Treatment Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 ONL Therapeutics

        • 14.12.1 ONL Therapeutics Company Profile

        • 14.12.2 ONL Therapeutics Macular Degeneration Treatment Market Performance

        • 14.12.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Macular Degeneration Treatment Industry Research Conclusions

    • 15.2 Macular Degeneration Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Macular Degeneration Treatment Industry Market Size (2018-2029)

    • Figure China Macular Degeneration Treatment Production Volume, Production Value and Growth Rate of Dry Age-related Macular Degeneration (2018-2029)

    • Figure China Macular Degeneration Treatment Production Volume, Production Value and Growth Rate of Wet Age-related Macular Degeneration (2018-2029)

    • Figure China Macular Degeneration Treatment Sales Volume, Sales Value and Growth Rate of Other Sales Channels (2018-2029)

    • Figure China Macular Degeneration Treatment Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Macular Degeneration Treatment Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

    • Figure North China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Macular Degeneration Treatment Market Size and Growth Rate from 2018-2029

    • Figure Macular Degeneration Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Macular Degeneration Treatment Market Share by Type in 2018

    • Figure China Macular Degeneration Treatment Market Share by Type in 2023

    • Figure China Macular Degeneration Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Macular Degeneration Treatment Production Volume and Growth Rate of Dry Age-related Macular Degeneration (2018-2023)

    • Figure China Macular Degeneration Treatment Production Volume and Growth Rate of Wet Age-related Macular Degeneration (2018-2023)

    • Figure China Macular Degeneration Treatment Market Share by Application in 2018

    • Figure China Macular Degeneration Treatment Market Share by Application in 2023

    • Figure China Macular Degeneration Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Macular Degeneration Treatment Market Size and Growth Rate of Other Sales Channels (2018-2023)

    • Figure China Macular Degeneration Treatment Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Macular Degeneration Treatment Market Size and Growth Rate of Ambulatory Surgical Centers (2018-2023)

    • Table China Macular Degeneration Treatment Production Volume by Region (2018-2023)

    • Table China Macular Degeneration Treatment Production Volume Share by Region (2018-2023)

    • Figure China Macular Degeneration Treatment Production Volume Share by Region (2018-2023)

    • Table China Macular Degeneration Treatment Production Value by Region (2018-2023)

    • Table China Macular Degeneration Treatment Production Value Share by Region (2018-2023)

    • Figure China Macular Degeneration Treatment Production Value Share by Region (2018-2023)

    • Table China Macular Degeneration Treatment Sales Volume by Region (2018-2023)

    • Table China Macular Degeneration Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Macular Degeneration Treatment Sales Volume Share by Region (2018-2023)

    • Table China Macular Degeneration Treatment Sales Value by Region (2018-2023)

    • Table China Macular Degeneration Treatment Sales Value Share by Region (2018-2023)

    • Figure China Macular Degeneration Treatment Sales Value Share by Region (2018-2023)

    • Table North China Macular Degeneration Treatment Production Volume by Type (2018-2023)

    • Table North China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Table North China Macular Degeneration Treatment Sales Volume by Application (2018-2023)

    • Table North China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Macular Degeneration Treatment Production Volume by Type (2018-2023)

    • Table Central China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Macular Degeneration Treatment Sales Volume by Application (2018-2023)

    • Table Central China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Macular Degeneration Treatment Production Volume by Type (2018-2023)

    • Table South China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Table South China Macular Degeneration Treatment Sales Volume by Application (2018-2023)

    • Table South China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Macular Degeneration Treatment Production Volume by Type (2018-2023)

    • Table East China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Table East China Macular Degeneration Treatment Sales Volume by Application (2018-2023)

    • Table East China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Macular Degeneration Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Macular Degeneration Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Macular Degeneration Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Macular Degeneration Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Macular Degeneration Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Macular Degeneration Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Macular Degeneration Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Macular Degeneration Treatment Sales Volume Share by Application (2018-2023)

    • Table REGENXBIO Inc Company Profile

    • Table REGENXBIO Inc Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)

    • Table Panoptica Company Profile

    • Table Panoptica Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)

    • Table Oxurion Company Profile

    • Table Oxurion Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)

    • Table Ocugen Inc Company Profile

    • Table Ocugen Inc Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)

    • Table Clover Therapeutics Company Profile

    • Table Clover Therapeutics Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)

    • Table Bausch Health Companies Inc Company Profile

    • Table Bausch Health Companies Inc Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)

    • Table Aerie Pharmaceutical Inc Company Profile

    • Table Aerie Pharmaceutical Inc Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)

    • Table MeiraGTx Company Profile

    • Table MeiraGTx Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)

    • Table ONL Therapeutics Company Profile

    • Table ONL Therapeutics Macular Degeneration Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US